Inicio › Leucemia mielógena aguda › Carolina del Norte › Charlotte
Ensayos clínicos de Leucemia mielógena aguda en Charlotte, NC
16 estudios para Leucemia mielógena aguda buscan participantes en centros de Charlotte y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ReclutandoFase 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ReclutandoFase 3
- Atrium Health, Charlotte
- Novant Health Charlotte, Charlotte
- Carolina Oncology Specialists, Charlotte
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ReclutandoFase 2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
ReclutandoFase 3
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
ReclutandoFase 2
- Novant Health Clinical Research, Charlotte
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
ReclutandoEstudio observacional
- Novant Health Weisiger Cancer Institute, Charlotte
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
ReclutandoFase 1/2
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
ReclutandoFase 1
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ReclutandoFase 1
- Atrium Health Levine Cancer Center, Charlotte
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
ReclutandoEstudio observacional
- Levine Cancer Institute, Charlotte
ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia
Reclutando
- Levine Cancer Insitute, Charlotte
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- Levine Children's Hospital, Charlotte
Clinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
ReclutandoFase 1/2
- Novant Health Cancer Institute, Charlotte
Más información sobre Leucemia mielógena aguda en MedlinePlus
Ensayos de Leucemia mielógena aguda en otras ciudades
- Houston, TX85 estudios
- New York City, NY51 estudios
- Boston, MA44 estudios
- Seattle, WA41 estudios
- Baldwin Park, CA40 estudios
- Columbus, OH35 estudios
- Philadelphia, PA34 estudios
- Durham, NC33 estudios
- Atlanta, GA31 estudios
- Tampa, FL29 estudios
- Chicago, IL26 estudios
- Portland, OR25 estudios
Otros estudios en Charlotte
- Cáncer (todos los tipos)27 estudios
- Cáncer de seno22 estudios
- Mieloma múltiple21 estudios
- Cáncer de pulmón de células no pequeñas19 estudios
- Obesidad16 estudios
- Sobrepeso15 estudios
- Cáncer del colon y del recto13 estudios
- Cáncer de ovario12 estudios
- Fallo cardíaco11 estudios
- Cáncer metastásico11 estudios
- Carcinoma de células escamosas de cabeza y cuello10 estudios
- Enfermedad de obstrucción pulmonar crónica9 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.